Meprobamate
Who holds supplier records for Meprobamate? 7 organisations hold a current record for Meprobamate: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), Taiwan (1) and Israel (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Meprobamate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/meprobamate
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Meprobamate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 20420 · latest filing Mar 2007
- FAR SPECIALTY PRODUCTS INC DBA FAR CHEMICALActive DMF 18193 · latest filing Mar 2005
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 20465 · latest filing Apr 2007
- HARMAN FINOCHEM LTDIndia Company GMP cert on recordActive DMF 20674 · latest filing Jul 2007
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 19680 · latest filing Aug 2006
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 23284 · latest filing Dec 2009
- Viyash Scientific LtdIndia Company GMP cert on recordActive DMF 19678 · latest filing Aug 2006
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Meprobamate are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- ALP PHARM BEIJING CO LTDInactive DMF 22423 · filed Dec 2008
- DANISCO ASInactive DMF 4092 · filed Feb 1981
- ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactive DMF 1089 · filed Oct 1967
- ALFA WASSERMANN SPAInactive DMF 482 · filed Apr 1962
- PRODOTTI CHIMICI DOTTORI REInactive DMF 441 · filed Jul 1961
Overview
Meprobamate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL979).
Chemical identity
- IUPAC name
- [2-(carbamoyloxymethyl)-2-methylpentyl] carbamate
- Canonical SMILES
- CCCC(C)(COC(=O)N)COC(=O)N
- InChIKey
- NPPQSCRMBWNHMW-UHFFFAOYSA-N
- Synonyms
- Amosene, Bamate, Equanil, Mepriam, Meprobamate, Meprobamate civ, Meprobamate component of equagesic, Meprobamate component of mepro-aspirin, Meprobamate component of micrainin, Meprobamate component of q-gesic, Meprobamato, Meprospan
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Meprobamate?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Meprobamate: Alembic Pharmaceuticals Limited (India), FAR SPECIALTY PRODUCTS INC DBA FAR CHEMICAL, Formosa Laboratories, Inc. (Taiwan), HARMAN FINOCHEM LTD (India), SOLARA ACTIVE PHARMA SCIENCES LTD (India), Taro Pharmaceutical Industries Ltd. (Israel) and Viyash Scientific Ltd (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Meprobamate Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 20420), FAR SPECIALTY PRODUCTS INC DBA FAR CHEMICAL (DMF 18193), Formosa Laboratories, Inc. (DMF 20465), HARMAN FINOCHEM LTD (DMF 20674), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 19680), Taro Pharmaceutical Industries Ltd. (DMF 23284) and Viyash Scientific Ltd (DMF 19678). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Meprobamate records mean?
5 organisations have only inactive Type II DMFs for Meprobamate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Meprobamate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Meprobamate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.